Review Timeline | CrossMark Policy | ClinMed Features

Need a supporting hand in manuscript formatting? Write to our team.
Assistance in presubmission | editorialoffice@clinmedjournals.org

International Journal of
Diabetes and Clinical Research
ISSN: 2377-3634
LETTER TO THE EDITOR | VOLUME 4, ISSUE 1 | OPEN ACCESS DOI: 10.23937/2377-3634/1410070

Could We Really Use Aloe Vera Food Supplements to Treat Diabetes?

Solomon Habtemariam

Pharmacognosy Research Laboratories & Herbal Analysis Services, University of Greenwich, Chatham-Maritime, UK

*Corresponding author: Solomon Habtemariam, Pharmacognosy Research Laboratories & Herbal Analysis Services, University of Greenwich, Chatham-Maritime, Kent ME4 4TB, UK, E-mail: s.habtemariam@herbalanalysis.co.uk

Received: March 28, 2017 | Accepted: May 17, 2017 | Published: May 20, 2017

Citation: Habtemariam S (2017) Could We Really Use Aloe Vera Food Supplements to Treat Diabetes? Int J Diabetes Clin Res 4:070. doi.org/10.23937/2377-3634/1410070

Copyright: © 2017 Habtemariam S. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

For thousands of years, mankind has used plants as a source of medicine either in their crude mixture forms or purified single chemical entities. While the use of crude plant extracts in prescription drugs today is extremely rare, we still have a significant number of our drug therapies tracing their origin back to natural products. In principle, drug therapeutic approach for complex metabolic disorders like diabetes and associated diseases, where a single key universally accepted biological target is not available, could be designed through a multifunctional (one drug → multitarget → multidisease/complex disease) or polypharmacology (multidrug → multitarget → multidisease/complex disease) principles [1]. On this basis, I read the diabetes UK website under the heading of "Herbal and Natural Therapies" [2] with great interest. The site lists herbs and spices that have been clinically shown to improve blood glucose control in type-2 diabetes patients and diabetes high risk group. Top in the list is the miraculous Aloe vera which has been further illustrated, as with other herbal medicines (Bilberry extract, Bitter melon, Cinnamon, Fenugreek, Ginger and Okra), in its own webpage [3]. To quote one statement from the website: "Preliminary research suggests that intake of Aloe vera juice can help improve blood glucose levels and may therefore be useful in treating people with diabetes". The beneficial effect of Aloe vera as a lipid lowering and wound healing agent along with other health benefits are also outlined. The site even gives guidance on where to buy Aloe vera and the health and beauty/food retailers among which 'The Body Shop' and 'Holland & Barrett' were specifically mentioned. Even though advice is given to patients in the main website to consult their doctor before using herbal medicines, the presentation of these potential antidiabetic medicines to the general public is nothing less than an endorsement by the highest authority in the UK for disseminating information on diabetes.

One should therefore ask a simple question:

Is there a consensus among the scientific community on using Aloe vera by its own to treat diabetes?

The answer is very simple and short - NO! Any diabetic patient who wishes to try out Aloe vera must be told that there is as such no overwhelming clinical evidence to justify its use as a replacement to metformin or other prescription antidiabetic drugs. This being the starting point of advice, one can highlight the antidiabetic therapeutic potential of the plant further.

After being used by our ancestors for thousands of years, our obsession for Aloe vera (L.) Burm. f. (Aloe barbadensis Mill; Family Asphodelaceae) products seems to be only growing by the year. Native to the East African/Mediterranean region, its traditional uses were employed by the Egyptians, Assyrians and Mediterranean civilizations as far back as 4000 BC. Its official record of usage in the western medicine was evident from the 14th Century as purgative and a topical treatment of wounds and skin conditions and it was incorporated in the London Pharmacopoeia by 1650; London Dispensatory in 1742; United States Pharmacopeia in 1820; British Pharmacopoeia in 1867; FDA list of approved food additives in 1959 [4]. Today, Aloe vera is one of the most widely utilized commercial plant by the food, beverage, pharmaceutical, herbal and cosmetic industries.

The therapeutic implication of Aloe vera for diabetes and associated diseases has been scrutinized through a number of scientific study models. Earlier studies from the 1950's to early 1990's showed that Aloe extracts, particularly the inner gel, possess antihyperglycemic effects in diabetic animals [5]. The controversies that arose due to reports of some preparations (in some studies) completely failed to show beneficial effects have been largely explained by variabilities in the preparation and doses employed and we now seem to have a good set of evidences from animal experiments to demonstrate the hypoglycaemic effect of the plant [6-10]. Beyond its effect on glucose control in animal models, the beneficial effects of Aloe vera in ameliorating the various diabetes-associated abnormalities have been documented in recent years. Among them were improvement of the diabetes-induced liver and kidney damage; its effect to reduce fat/cholesterol level; its antioxidant potential, etc. [11-18]. Variabilities in the data with respect to the degree of efficacy have always been an issue, however, and the lack of one standardized drug preparation that all scientific studies could utilize remains a major problem. A number of clinical trials from the 1980's have also been conducted and in almost all cases, some kind of beneficial effects that have been observed in animal studies, but most importantly a reduction in blood glucose level, have been documented [5,19-30] Unfortunately, most of the clinical studies on Aloe vera so far have been brutally criticized for their limitations due to heterogeneity of the drug preparations, doses, patient's status (e.g., uncontrolled dietary and physical state, etc.), study methodology (blinding, duration of study, etc.) and the results itself which have been often contradictory (e.g. cholesterol lowering effect).

Hence, what has not been shown for Aloe vera is very crucial - Is the observed benefit merit its use as an alternative drug therapy to the known clinically useful drugs? This unfortunately has not been answered and the use of Aloe vera by its own as antidiabetic therapy cannot be advocated from the clinical evidences available so far. For example, a small reduction of blood glucose in short term studies, no matter how statistically significant, does not warrant a plant extract to be used as antidiabetic therapy. On the other hand, such effect could have additive effect when used together with prescription drugs and endanger a diabetic patient due to acute hypoglycemia. A large scale, well-controlled, long-term and multicentre clinical trials on universally accepted standardised Aloe vera preparation is thus needed to answer this question. Recent meta-analysis studies [31-33] also came with the conclusion that only a well-designed comprehensive clinical study would be able to unequivocally confirm the antidiabetic clinical potential of Aloe vera. In the meantime, organizations like Diabetes UK with responsibility in disseminating accurate information to the general public should be a little more cautious when listing available antidiabetic drug therapies and their sources.

While visiting some local sources of Aloe vera products recommended by Diabetes UK, I could not see anything of relevance to diabetes at 'The Body Shop' (only skin care products of Aloe vera were on display) while the 'Holland & Barrett' appeared to have a good range of products (Figure 1). None of them are of course sold as medicine or specific therapy for diabetes but are formulated/stabilised products in capsule, tablet or juice forms with most of them seem to be targeting the gastrointestinal system. They contain aloe leaf inner gel or whole leaf extract or both while some contain a blend of several other plant extracts. The biggest source of controversy in using such products for chronic disease like diabetes will arise from the diversity of preparations and composition of active ingredients in these products - hence giving rise to variability in their health benefit outcomes. Even if the observed, sometimes marginal, antidiabetic effect of Aloe vera warrants its clinical use, one would wonder again which one of these products the general public should choose to treat diabetes. Overall, there are few unresolved issues that weigh against recommending the use of Aloe vera for treating diabetes by its own. Products which are blended or optimised for other health benefits should not be even considered suitable for diabetes therapy until an overwhelming body of scientific evidences are provided in their favour. In the absence of unequivocal clinical evidence available for such formulations, the justification of using these preparations for diabetes far beyond food supplements is based only on judgement on balance of probabilities.

Figure 1: Aloe vera products available to the general public at the Holland & Barrett outlet. View Figure 1

Conflict of Interest

The author declares no conflict of interest.


No financial assistance either from internal of external sources were obtained for this contribution.


  1. Habtemariam S (2017) Going back to the good old days: The merit of crude plant drug mixtures in the 21st century. Int J Complement Alt Med 6: 00182.

  2. http://www.diabetes.co.uk/Diabetes-herbal.html.

  3. http://www.diabetes.co.uk/natural-therapies/aloe-vera.html.

  4. http://www.cosmesi.it/Portals/7/Documenti/Monograph%20AHP_Aloe_vera_leaf_.pdf.

  5. Yongchaiyudha S, Rungipitarangsi V, Bunyapraphatsara N, Chokechaijaroenporn O (1996) Antidiabetic activity of Aloe vera L. juice. I. Clinical trial in new cases of diabetes mellitus. Phytomedicine 3: 241-243.

  6. Rajasekaran S, Sivagnanam K, Ravi K, Subramanian S (2004) Hypoglycemic effect of Aloe vera gel on streptozotocin-induced diabetes in experimental rats. J Med Food 7: 61-66.

  7. Okyar A, Can A, Akev N, Baktir G, Sütlüpinar N (2001) Effect of Aloe vera leaves on blood glucose level in type I and type II diabetic rat models. Phytother Res 15: 157-161.

  8. Afaf I Abuelgasim, Maha KM Osman, B Elmahdi (2008) Effects of Aloe vera (elsabar) ethanolic extract on blood glucose level in Wistar albino rats. J Appl Sci Res 4: 1841-1845.

  9. Kim K, Kim H, Kwon J, Lee S, Kong H, et al. (2009) Study on the hypoglycemic and hypolipidemic effects of processed Aloe vera gel in a mouse model of non-insulin-dependent diabetes mellitus. Phytomedicine 16: 856-863.

  10. Yimam M, Zhao J, Corneliusen B, Pantier M, Brownell L, et al. (2014) Blood glucose lowering activity of aloe based composition, UP780, in alloxan induced insulin dependent mouse diabetes model. Diabetol Metab Syndr 6: 61.

  11. Bolkent S, Akev N, Ozsoy N, Sengezer-Inceli M, Can A, et al. (2004) Effect of Aloe vera (L.) Burm fil. leaf gel. and pulp extracts on kidney in type II diabetic rat model. Indian J Exp Biol 42: 48-52.

  12. Can A, Akev N, Ozsoy N, Bolkent S, Arda BP, et al. (2004) Effect of Aloe vera leaf gel and pulp extracts on the liver in type-II diabetic rat models. Biol Pharm Bull 27: 694-698.

  13. Lim BO, Seong NS, Choue RW, Kim JD, Lee HY, et al. (2003) Efficacy of dietary Aloe vera supplementation on hepatic cholesterol and oxidative status in aged rats. J Nutr Sci Vitamonol 49: 292-296.

  14. Rajasekaran S, Sivagnanam K, Subramanian S (2005) Antioxidant effect of Aloe vera gel extract in streptozotocin-induced diabetes in rats. Pharmacol Rep 57: 90-96.

  15. Rajasekaran S, Ravi K, Sivagnanam K, Subramanian S (2006) Beneficial effects of Aloe vera gel extract on lipid profile status in rats with streptozotocin diabetes. Clin Exp Pharmacol Physiol 33: 232-237.

  16. Rajasekaran S, Aathishsekar D (2007) Therapeutic evaluation of Aloe vera leaf gel extract on glycoprotein components in rats with streptozotocin diabetes. J Pharmacol Toxicol 2: 380-385.

  17. Shin E, Shin S, Kong H, Lee S, Do SG, et al. (2011) Dietary Aloe reduces adipogenesis via the activation of AMPK and suppresses obesity-related inflammation in obese mice. Immune Netw 11: 107-113.

  18. Shin S, Kim S, Oh HE, Kong H, Shin E, et al. (2012) Dietary Aloe QDM complex reduces obesity-induced insulin resistance and adipogenesis in obese mice fed a high-fat diet. Immune Netw 12: 96-103.

  19. Agarwal OP (1985) Prevention of atheromatous heart disease. Angiology 36: 485-492.

  20. Ghannam N, Kingston M, Al-Meshaal IA, Tariq M, Parman NS, et al. (1986) The antidiabetic activity of aloes: preliminary clinical and experimental observations. Horm Res 24: 288-294.

  21. Bunyapraphatsara N, Yongchaiyudha S, Rungipitarangsi V, Chokechaijaroenporn O (1996) Antidiabetic activity of Aloe vera L. juice. II. Clinical trial in diabetes mellitus patients in combination with glibenclamide. Phytomedicine 3: 245-248.

  22. Chalaprawat M (1997) The hypoglycemic effects of aloe vera in Thai diabetic patients. J Clin Epidemiol 50: S3.

  23. Devaraj S, Jialal R, Jialal I, Rockwood J (2009) Effect of Aloe vera supplements in patients with Pre-Diabetes. FASEB J 23.

  24. Yagi A, Hegazy S, Kabbash A, Wahab EA (2009) Possible hypoglycemic effect of Aloe vera L. high molecular weight fractions on type 2 diabetic patients. Saudi Pharm J 16: 209-215.

  25. Fallah HH, Kianbakht S, Hajiaghaee R, Afkhami AM, Bonakdaran A, et al. (2012) Aloe vera leaf gel in treatment of advanced type 2 diabetes mellitus needing insulin therapy: a randomized double-blind placebo-controlled clinical trial. J Med Plants 11: 19-27.

  26. Huseini HF, Kianbakht S, Hajiaghaee R, Dabaghian FH (2012) Anti-hyperglycemic and anti-hypercholesterolemic effects of Aloe vera leaf gel in hyperlipidemic type 2 diabetic patients: a randomized double-blind placebo-controlled clinical trial. Planta Med 78: 311-316.

  27. Devaraj S, Yimam M, Brownell LA, Jialal I, Singh S, et al. (2013) Effects of Aloe vera supplementation in subjects with prediabetes/metabolic syndrome. Metab Syndr Relat Disord 11: 35-40.

  28. Choi HC, Kim SJ, Son KY, Oh BJ, Cho BL (2013) Metabolic effects of aloe vera gel complex in obese prediabetes and early non-treated diabetic patients: Randomized controlled trial. Nutrition 29: 1110-1114.

  29. Choudhary M, Kochhar A, Sangha J (2014) Hypoglycemic and hypolipidemic effect of Aloe vera L. in non-insulin dependent diabetics. J Food Sci Technol 51: 90-96.

  30. Pradeep AR, Garg V, Raju A, Singh P (2016) Adjunctive local delivery of Aloe vera gel in patients with type 2 diabetes and chronic periodontitis: A randomized, controlled clinical trial. J Periodontol 87: 268-274.

  31. Dick WR, Fletcher EA, Shah SA (2016) Reduction of Fasting Blood Glucose and Hemoglobin A1c using oral Aloe vera: A meta-analysis. J Altern Complement Med 22: 450-457.

  32. Gao Y, Jiang T, Mei S, Zhang S, Zhu C, et al. (2016) Meta-analysis of Aloe vera for the prevention and treatment of chemotherapy-induced phlebitis. Int J Clin Exp Med 9: 9642-9650.

  33. Zhang Y, Liu W, Liu D, Zhao T, Tian H (2016) Efficacy of Aloe vera supplementation on prediabetes and early non-treated diabetic patients: A systematic review and meta-analysis of randomized controlled trials. Nutrients 8: 388.